Related Experiment Video
Updated: Aug 21, 2026

Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines
Published on: November 25, 2017
[Diagnostics of mucopolysaccharidoses presented through the case of Sanfilippo syndrome]
Insights
Mucopolysaccharidoses (MPS) are rare genetic disorders. This case study identifies Mucopolysaccharidosis type A (MPS III) in a child with developmental delays and physical abnormalities, highlighting diagnostic challenges.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Mucopolysaccharidoses (MPS) are inherited metabolic disorders characterized by the lysosomal accumulation of glycosaminoglycans.
- These progressive diseases result from deficiencies in specific lysosomal enzymes responsible for glycosaminoglycan degradation.
Observation:
- A five-year-old boy presented with psychomotor retardation, distinctive facial features, skeletal deformities, and hepatosplenomegaly.
- Radiographic examination confirmed Dysostosis epiphysealis multiplex, and he exhibited moderate intellectual disability (IQ 48).
Findings:
- Metabolic screening revealed increased urinary glycosaminoglycan excretion, confirmed by a positive toluidine blue test.
- Enzyme analysis identified a deficiency in heparin sulfate sulfatase, leading to the diagnosis of Mucopolysaccharidosis type A (Sanfilippo syndrome).
Implications:
- The genetic heterogeneity of MPS poses challenges for molecular diagnostics and carrier identification.
- Prenatal diagnosis via chorionic villus sampling was recommended for subsequent pregnancies.
- The patient's prognosis is poor, with expected mortality in the second decade due to progressive neurological decline.
Abstract:
Mucopolysaccharidoses (MPS) are recessive inheritable, progressive diseases of disordered degradation and storage of acid glucosaminoglycans. A five-year old child with psychomotor development retardation, which started at his age of two, was presented in our study. Clinical examination showed big head with rough facial features, skeleton deformities and hepatosplenomegaly. The diagnosis Dysostosis epifisealis multiplex was also confirmed by the X-ray examination of skeleton. Karyotype: 46, XY. Mental retardation: IQ--48. Clinically suspected mucopolysaccharidosis called for metabolic screening of first morning urine and the positive toluidine blue test result indicated the increased excretion of mucopolysaccharides. Further enzyme analyses of peripheral blood leucocytes confirmed the heparin sulphate sulphatase deficiency on the basis of which A (MPS III) Sanfilippo syndrome was defined. Our patient was born as a twin sibling. The other sibling is clinically healthy and of normal metabolic screening. It was not possible to define precisely the healthy heterozygote by testing the enzyme activities. A large number of mutations at various loci and big genetic heterogeneity of mucopolysaccharidoses made molecular diagnostics difficult. In the subsequent pregnancy, the mother was recommended prenatal diagnostics by enzyme analysis from the cultured chorionic villus. The prognosis of the presented patient is bad, the course of the disease is progressive and the patient can be expected to die in spastic tetraplegia in the second decade of life. The treatment is symptomatic for the time being.
More Related Videos
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015
05:32High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
Published on: January 19, 2022